Abstract |
Eupafolin is a flavone isolated from Artemisia princeps Pampanini (family Asteraceae). The aim of this study was to examine the anti-inflammatory effects of eupafolin in lipopolysaccharide (LPS)-treated RAW264.7 macrophages and LPS-induced mouse skin and lung inflammation models and to identify the mechanism underlying these effects. Eupafolin decreased the LPS-induced release of inflammatory mediators (iNOS, COX-2 and NO) and proinflammatory cytokines (IL-6 and TNF-α) from the RAW264.7 macrophages. Eupafolin inhibited the LPS-induced phosphorylation of p38 MAPK, ERK1/2, JNK, AKT and p65 and the nuclear translocation of p65 and c-fos. These effects were mainly mediated by the inhibition of JNK. In the mouse paw and lung models, eupafolin effectively suppressed the LPS-induced edema formation and down-regulated iNOS and COX-2 expression. These results demonstrated that eupafolin exhibits anti-inflammatory properties and suggested that eupafolin can be developed as an anti-inflammatory agent.
|
Authors | Chin-Chaun Chen, Ming-Wei Lin, Chan-Jung Liang, Shu-Huei Wang |
Journal | PloS one
(PLoS One)
Vol. 11
Issue 7
Pg. e0158662
( 2016)
ISSN: 1932-6203 [Electronic] United States |
PMID | 27414646
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Flavones
- Interleukin-6
- Lipopolysaccharides
- Tumor Necrosis Factor-alpha
- Nitric Oxide
- Nitric Oxide Synthase Type II
- Cyclooxygenase 2
- eupafolin
|
Topics |
- Animals
- Anti-Inflammatory Agents
(pharmacology)
- Cyclooxygenase 2
(metabolism)
- Flavones
(pharmacology)
- Inflammation
(chemically induced, metabolism)
- Interleukin-6
(metabolism)
- Lipopolysaccharides
- Lung
(drug effects, metabolism)
- Macrophages
(drug effects, metabolism)
- Mice
- Nitric Oxide
(metabolism)
- Nitric Oxide Synthase Type II
(metabolism)
- Phosphorylation
- Signal Transduction
(drug effects)
- Skin
(drug effects, metabolism)
- Tumor Necrosis Factor-alpha
(metabolism)
|